COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture
- 1 August 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 135 (2), 163-181
- https://doi.org/10.1111/j.1365-2133.1996.tb01143.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Efficient strategy for the detection of mutations in acrogeric Ehlers-danlos syndrome type IVHuman Mutation, 1995
- Marked heterogenicity in COL3A1 mutations that produce the EDS type IV phenotypeMatrix Biology, 1994
- The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.Journal of Medical Genetics, 1993
- Single base mutation that substitutes glutamic acid for glycine 1021 in the COL3A1 gene and causes Ehlers–Danlos syndrome type IVAmerican Journal of Medical Genetics, 1993
- Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV.Journal of Medical Genetics, 1991
- Type III collagen mutations cause fragile cerebral arteriesBritish Journal Of Neurosurgery, 1991
- Prenatal diagnosis and prevention of inherited abnormalities of collagenJournal of Inherited Metabolic Disease, 1989
- Type III collagen mutations in Ehlers Danlos Syndrome type IV and other related disordersClinical and Experimental Dermatology, 1988
- Isolation and Characterization of the Human Fibrillar Collagen GenesaAnnals of the New York Academy of Sciences, 1985
- Ehlers–Danlos syndrome type IV mimicking non-accidental injury in a childBritish Journal of Dermatology, 1984